1. Adler, C., Ketter, T., Frye, M.A., Yang, R., Bauer, M., 2014. Randomized, double-blind, placebo-controlled trial of adjunctive armodafinil (150 mg/day) in adults with bipolar I depression: Safety and primary efficacy findings. Presented at: 167th Annual Meeting of the American Psychiatric Association; May 3–7, 2014; New York, NY. Poster NR6-038.
2. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder;Altshuler;J. Clin. Psychiatry,2002
3. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,2013
4. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression - lack of manic induction;Amsterdam;J. Affect. Disord.,2005
5. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders;Baldessarini;Psychiatr. Serv.,2007